Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 19/20 | 0.73 |
| ▸ | SCN5A | Q14524 | 10/20 | 0.73 |
| ▸ | SCN7A | Q01118 | 5/20 | 0.61 |
| ▸ | SCN2B | O60939 | 1/20 | 0.56 |
| ▸ | SCN1A | P35498 | 1/20 | 0.56 |
| ▸ | SCN4A | P35499 | 1/20 | 0.56 |
| ▸ | SCN1B | Q07699 | 1/20 | 0.56 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.56 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15536874 | 0.91 | SCN9A (0.81) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL15535775 | 0.87 | SCN9A (0.74) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL15536660 | 0.86 | SCN9A (0.69) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL15536896 | 0.85 | SCN9A (0.72) | SCN9ASCN5A | |
| SCHEMBL15536442 | 0.85 | SCN9A (1.00) | SCN9ASCN5ASCN7A | |
| SCHEMBL15536888 | 0.84 | SCN9A (1.00) | SCN9ASCN5ASCN7A | |
| SCHEMBL19075828 | 0.82 | SCN9A (0.81) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL17423045 | 0.82 | SCN9A (0.81) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL15535944 | 0.82 | SCN9A (0.70) | SCN9ASCN5ASCN7ASCN2BSCN1A | |
| SCHEMBL15536246 | 0.81 | SCN9A (1.00) | SCN9ASCN5ASCN7ASCN2BSCN1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2855428-A1 | N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN | Genentech, Inc. (US) | 2015-04-08 | — | — | EP | disclosed |
| US-8952169-B2 | N-substituted benzamides and methods of use thereof | XENON PHARMACEUTICALS INC. (CA) | 2015-02-10 | — | — | US | disclosed |
| US-8952169-B2 | N-substituted benzamides and methods of use thereof | XENON PHARMACEUTICALS INC. (CA) | 2015-02-10 | — | — | US | disclosed |
| WO-2013177224-A1 | N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN | GENENTECH, INC. (US) | 2013-11-28 | — | — | WO | disclosed |